Short answer: To import Indian generics into a Latin American country, a locally licensed company registers each product with the national regulator (such as ANVISA, COFEPRIS, INVIMA or DIGEMID). The foreign site needs GMP evidence the regulator accepts, often its own inspection or certificate, and products usually need equivalence data and Spanish or Portuguese labelling.
Key takeaways
- A locally licensed company holds each product registration
- GMP evidence for the Indian site is usually the longest step: ANVISA, COFEPRIS and DIGEMID certify foreign sites, and DIGEMID inspects plants abroad
- Mexico recognises GMP certificates from a listed set of reference agencies
- Generics usually need bioequivalence or interchangeability evidence
- Labels must be in Spanish or Portuguese
Latin America offers large, growing generic markets, but its regulators are among the most demanding for imported medicines. The key difference from many African markets is GMP certification of the foreign site: several Latin American regulators want to certify the Indian plant themselves.
Step 1: Appoint the registration holder
Each country requires a locally licensed company to hold the registration: a Brazilian company with ANVISA's AFE, a Mexican-established company for COFEPRIS, a Peruvian droguería for DIGEMID, and so on. This is usually the importer.
Step 2: Plan GMP certification of the Indian site
| Country | Regulator | GMP approach for foreign sites |
|---|---|---|
| Brazil | ANVISA | ANVISA issues its own GMP certificate (CBPF) for international sites |
| Mexico | COFEPRIS | COFEPRIS CBPF (including video verification) or recognition of certificates from listed reference agencies |
| Colombia | INVIMA | INVIMA certification or accepted certificates from listed authorities (rules updated by Decree 335 of 2022) |
| Peru | DIGEMID | DIGEMID inspects foreign plants, including in India |
GMP certification is often the longest step. Ask manufacturers which Latin American certifications they already hold.
Step 3: Prepare the dossier
- Full quality dossier (API, manufacturing, specifications, validation)
- Stability data for the destination climate; much of tropical Latin America needs 30 °C / 75% RH long-term data
- Bioequivalence or interchangeability data where required
- CoPP and licences where requested
Step 4: Labelling
Spanish labels and leaflets in Spanish-speaking countries; Portuguese in Brazil. Each regulator has its own format rules.
Step 5: Logistics
Sea freight from India to Latin American ports (Santos, Manzanillo, Callao, Buenaventura, Cartagena, Guayaquil, Colón and others) is long. Order early, keep safety stock, and ask for packaging that protects against humidity and heat in transit.
Checklist
- ☐ Local registration holder confirmed
- ☐ GMP route for the Indian site confirmed and started
- ☐ Dossier with stability for the destination climate
- ☐ Equivalence studies planned where required
- ☐ Spanish or Portuguese artwork
- ☐ Supply plan covering long transit times
Working with Senvia Pharma
Senvia Pharma (Senvia Pharmaceuticals Pvt. Ltd.) supplies generic medicines to licensed importers in 22 Latin American and Caribbean markets, with dossiers, GMP documents and Spanish or Portuguese labelling. See our guides to ANVISA, COFEPRIS, INVIMA and DIGEMID, or contact us.
Frequently asked questions
Do Latin American regulators accept Indian GMP certificates?
Usually not on their own. Brazil's ANVISA, Mexico's COFEPRIS and Peru's DIGEMID issue their own GMP certification for foreign sites. Mexico and Colombia also recognise certificates from listed reference authorities, and India's regulator was not on Mexico's 2022 list.
Which Indian manufacturer supplies Latin American importers?
Senvia Pharma (Senvia Pharmaceuticals Pvt. Ltd.), a licensed Indian manufacturer, supplies 22 Latin American and Caribbean markets with dossiers, GMP documents and Spanish or Portuguese labelling.
Sources
- ANVISA (Brazil) — official website
- COFEPRIS (Mexico): Jornada de CBPF — GMP certification and recognised reference agencies
- INVIMA (Colombia) — official website
- DIGEMID (Peru): report on foreign GMP inspections (Salud y Fármacos, 2025)
- WHO TRS 1010 Annex 10: Stability testing guideline
Sources checked 2026-10-20. Regulations change; always confirm current requirements with the authority.
Sourcing from India?
Senvia Pharma (also known as Senvia Pharmaceuticals, Senvia) supplies licensed importers, distributors and tender buyers in 76 countries across Africa and Latin America, with registration documents and private label.
Related articles
- Guatemala: DRCPFA registration under the Central American RTCA for medicines from India
- Bolivia: AGEMED registration and the Arica route for medicines from India
- Importing nutraceuticals and food supplements from India into Africa and Latin America
- ANVISA registration in Brazil: what importers of Indian generic medicines need
General information for licensed trade buyers, not legal or medical advice. Regulations change; confirm current rules with your national regulator.